Published in Medical Letter on the CDC and FDA, October 1st, 2006
Study 1: Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine.
According to a recent report, "A current or previous schistosome infection might compromise the efficacy of a schistosome vaccine administered to humans. We have therefore investigated the influence of infection on vaccination, using the baboon as the model host and irradiated Schistosoma mansoni cercariae as the vaccine."
"Protection, determined from worm burdens in test and controls, was not diminished when vaccination was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA